(Q36972090)

17 August 2017

1 reference

title

Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis (English)

1 reference

17 August 2017

1 reference

5

Harri Sintonen

1 reference

17 August 2017

Pekka Kuukasjärvi

1

1 reference

17 August 2017

Pirjo Räsänen

series ordinal

2

1 reference

17 August 2017

Antti Malmivaara

series ordinal

3

1 reference

17 August 2017

Pasi Aronen

series ordinal

4

1 reference

17 August 2017

language of work or name

1 reference

1 January 2007

1 reference

International Journal of Technology Assessment in Health Care

17 August 2017

published in

1 reference

17 August 2017

volume

23

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

473-479

1 reference

Cost-effectiveness of drug-eluting coronary stents in Quebec, Canada.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

Economic evaluation of sirolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

Coronary artery stents: a rapid systematic review and economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

Antiproliferative drug-eluting stents: systematic review of the benefits and estimate of economic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

Economic impact of drug-eluting stents on hospital systems: a disease-state model

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070560

7 January 2021

10.1017/S0266462307070560

Identifiers

DOI

1 reference

17 August 2017

1 reference